It’s likely that Merck’s COVID-19 pill will be authorized in the U.S. this month but it’s expected to be restricted to certain high-risk people.
It’s likely that Merck’s COVID-19 pill will be authorized in the U.S. this month but it’s expected to be restricted to certain high-risk people.